| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $670K | -51.0% |
| SG&A Expense | $7.5M | +5.0% |
| Operating Income | -$7.8M | +1.1% |
| Pre-tax Income | -$7.5M | +4.3% |
| Income Tax | $0 | — |
| Net Income | -$7.5M | +4.3% |
| EPS (Basic) | -$0.69 | +59.6% |
| EPS (Diluted) | -$0.69 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.9M | +16.8% |
| Current Assets | $29.0M | +16.7% |
| Total Assets | $29.5M | +18.1% |
| Current Liabilities | $350K | +104.2% |
| Stockholders' Equity | $29.1M | +17.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | +38.7% |
| Investing Cash Flow | -$7K | +58.5% |
| Financing Cash Flow | $10.9M | -23.5% |
| +59.6% |